Skip to main content
. 2024 Oct 22;18(5):639–646. doi: 10.31616/asj.2024.0194

Table 1.

Descriptive characteristics of unmatched patients (n=153,500)

Characteristic Cannabis users (n=642) Cannabis non-users (n=152,858) p-value
Age (yr) <0.001
 15–19 0 128 (0.08)
 20–24 0 572 (0.37)
 25–29 20 (3.23) 1,341 (0.88)
 30–34 39 (6.30) 3,237 (2.12)
 35–39 59 (9.53) 5,438 (3.56)
 40–44 72 (11.63) 8,108 (5.30)
 45–49 94 (15.19) 11,655 (7.62)
 50–54 101 (16.32) 16,248 (10.63)
 55–59 114 (18.42) 20,846 (13.64)
 60–64 77 (12.44) 23,128 (15.13)
 65–69 43 (6.95) 23,302 (15.24)
 70–74 0 21,975 (14.38)
 75–79 0 14,627 (9.57)
 80–85 0 2,253 (1.47)
Gender <0.001
 Female 312 (48.60) 88,430 (57.85) <0.001
 Male 330 (51.40) 64,428 (42.15)
Comorbidity
 Depression 375 (58.41) 25,936 (16.97) <0.001
 Anxiety 378 (58.88) 22,778 (14.90) <0.001
 SDoH disparity 253 (39.41) 19,810 (12.96) <0.001
Levels of fusion
 Single 425 (66.20) 104,028 (68.06) 0.34
 Two 101 (15.73) 20,288 (13.27) 0.08
 Three 116 (18.07) 28,542 (18.67) 0.73
Insurance type <0.001
 Cash 0 118 (0.08)
 Commercial 369 (63.84) 101,922 (66.68)
 Government 0 3,615 (2.36)
 Medicaid 131 (22.66) 6,613 (4.33)
 Medicare 78 (13.49) 39,326 (25.73)
 Unknown 0 1,264 (0.83)
Preoperative opioid usea)
 Opioid naïve 315 (49.07) 97,307 (63.66) <0.001
 ≤34 MME 13 (2.02) 2,021 (1.32) 0.17
 35–74 MME 12 (1.87) 2,014 (1.32) 0.29
 75–89 MME 0 662 (0.43) 0.67
 90–100 MME 0 810 (0.53) 0.26
 ≥100 MME 0 595 (0.39) >0.999

Values are presented as number (%).

SDoH, social determinants of health; MME, morphine milliequivalents.

a)

Preoperative opioid use within 30 days of surgery.